Tsuyoshi Sugiyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tsuyoshi Sugiyama has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Keita Takahashi
Department of Microbiology and Immunology, Gifu Pharmaceutical University , Gifu
3 shared publications - Naoki Inoue
Microbiology and Immunology, Gifu Pharmaceutical University, Gifu, Japan
3 shared publications - Hiroshi Ueda
United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Yanagido 1-1, Gifu 501-1193, Japan
2 shared publications Nagisa Tokunoh
Department of Microbiology and Immunology, Gifu Pharmaceutical University , Gifu
2 shared publicationsShiori Watanabe
Department of Pharmacy, Laboratory of Microbiology and Immunology, Gifu Pharmaceutical University, Gifu 501-1196, Japan
2 shared publicationsTakahiro Nagase
Kazusa DNA Research Institute, Chiba, Japan
2 shared publications
Latest Publications
- Open Access
- 11 January 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (2) , 101579
The Rho guanine nucleotide exchange factor PLEKHG1 is activated by interaction with and phosphorylation by Src family kinase member FYN
- 11 January 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (2) , 101579
Open AccessThe Rho guanine nucleotide exchange factor PLEKHG1 is activated by interaction with and phosphorylation by Src family kinase member FYN
- Open Access
- 1 October 2021
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 5 (10) , 870-883
Intimate Adhesion Is Essential for the Pathogen-Specific Inflammatory and Immune Responses in the Gut of Mice Infected with Citrobacter rodentium
Citrobacter rodentium is a murine pathogenic bacterium that adheres to intestinal epithelial cells, resulting in loss of microvilli and pedestal formation, and alters multiple cellular processes, including actin dynamics. Translocated intimin receptor (Tir), one of its virulence factors, functions as receptor for intimin, a bacterial adhesin, thereby mediating bacterial adhesion to epithelial cells. Although robust immune responses are induced to eliminate pathogenic bacteria in the host, they are suppressed against harmless commensal bacteria. The mechanism(s) underlying such a differentiation remains unclear. This study sought to determine the roles of intimate adhesion in the induction of specific immune responses upon C. rodentium infection. To this end, microbiota-depleted mice were infected with the Tir-F strain expressing full-length Tir or mutant strains expressing the C-terminal truncated Tir that is defective in intimin binding and host cell actin polymerization. There were no differences in the colonization kinetics and Abs responses against C. rodentium LPS among the strains, whereas Abs against the virulence factors were only produced on Tir-F infection. Although there were no differences in the virulence factors mRNA expression levels, colonic hyperplasia, and bacterial translocation to the systemic organs irrespective of the strain, adhesion to colonic epithelial cells was reduced in the mutant strain–infected mice. Furthermore, transcriptomic analysis indicated that robust inflammatory and immune responses were only induced in the Tir-F–infected group and were suppressed in the mutant-infected groups. Taken together, these findings suggest that Tir-mediated intimate adhesion induces inflammatory and immune responses, resulting in the induction of virulence factor–specific Abs.
- 1 October 2021
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 5 (10) , 870-883
Open AccessIntimate Adhesion Is Essential for the Pathogen-Specific Inflammatory and Immune Responses in the Gut of Mice Infected with Citrobacter rodentium
Citrobacter rodentium is a murine pathogenic bacterium that adheres to intestinal epithelial cells, resulting in loss of microvilli and pedestal formation, and alters multiple cellular processes, including actin dynamics. Translocated intimin receptor (Tir), one of its virulence factors, functions as receptor for intimin, a bacterial adhesin, thereby mediating bacterial adhesion to epithelial cells. Although robust immune responses are induced to eliminate pathogenic bacteria in the host, they are suppressed against harmless commensal bacteria. The mechanism(s) underlying such a differentiation remains unclear. This study sought to determine the roles of intimate adhesion in the induction of specific immune responses upon C. rodentium infection. To this end, microbiota-depleted mice were infected with the Tir-F strain expressing full-length Tir or mutant strains expressing the C-terminal truncated Tir that is defective in intimin binding and host cell actin polymerization. There were no differences in the colonization kinetics and Abs responses against C. rodentium LPS among the strains, whereas Abs against the virulence factors were only produced on Tir-F infection. Although there were no differences in the virulence factors mRNA expression levels, colonic hyperplasia, and bacterial translocation to the systemic organs irrespective of the strain, adhesion to colonic epithelial cells was reduced in the mutant strain–infected mice. Furthermore, transcriptomic analysis indicated that robust inflammatory and immune responses were only induced in the Tir-F–infected group and were suppressed in the mutant-infected groups. Taken together, these findings suggest that Tir-mediated intimate adhesion induces inflammatory and immune responses, resulting in the induction of virulence factor–specific Abs.
- Open Access
- 1 January 2018
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 41 (2) , 190-197
Peyer’s Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 2018
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 41 (2) , 190-197
Open AccessPeyer’s Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 19 September 2012
- Published by Elsevier in Cellular Signalling
- Vol. 25 (1) , 41-49
Identification of a Rho family specific guanine nucleotide exchange factor, FLJ00018, as a novel actin-binding protein
- 19 September 2012
- Published by Elsevier in Cellular Signalling
- Vol. 25 (1) , 41-49
Identification of a Rho family specific guanine nucleotide exchange factor, FLJ00018, as a novel actin-binding protein
- Open Access
- 1 June 2007
- Published by Wiley in Microbiology and Immunology
- Vol. 51 (6) , 581-592
Neutralizing Activity of Polyvalent Gb3, Gb2 and Galacto‐Trehalose Models against Shiga Toxins
Shiga toxin (Stx) is one of the most critical factors in the development of hemolytic uremic syndrome and other systemic complications following enterohemorrhagic Escherichia coli (EHEC) infection. Substances neutralizing Stx by interfering with toxin‐receptor binding have been explored as therapeutic candidates for EHEC infection. In this study, we examined globotriaosyl (Gb3), galabiosyl (Gb2) and galacto‐trehalose, each of which was synthetically conjugated with a polyacrylamide backbone, for Stx‐neutralizing activity. Galacto‐trehalose was designed as a Gb2 mimicking, unnatural Stx‐ligand that was expected to show tolerance to enzymatic degradation in vivo. Galacto‐trehalose copolymer showed neutralizing activity against Stx‐1 but not Stx‐2 in a HeLa cell cytotoxicity assay. It was thought that galacto‐trehalose copolymer could be a lead compound for the treatment of Stx‐mediated diseases, although it requires modification to show neutralizing activity to Stx‐2. The Gb3 copolymer with high sugar unit density showed stronger neutralizing activity against Stx‐2 than those with lower density. However, the density‐dependency of the neutralizing activity was less obvious against Stx‐1. Intravenous administration of the Gb3 copolymer prevented death in mice lethally infected with Stx‐1‐ and Stx‐2‐producing E. coli O157:H7. Thus, we demonstrated that the artificial Gb3 copolymer could neutralize Stx‐1 and the more clinically relevant Stx‐2 in vitro and effectively inhibit Stx toxicity in vivo.
- 1 June 2007
- Published by Wiley in Microbiology and Immunology
- Vol. 51 (6) , 581-592
Open AccessNeutralizing Activity of Polyvalent Gb3, Gb2 and Galacto‐Trehalose Models against Shiga Toxins
Shiga toxin (Stx) is one of the most critical factors in the development of hemolytic uremic syndrome and other systemic complications following enterohemorrhagic Escherichia coli (EHEC) infection. Substances neutralizing Stx by interfering with toxin‐receptor binding have been explored as therapeutic candidates for EHEC infection. In this study, we examined globotriaosyl (Gb3), galabiosyl (Gb2) and galacto‐trehalose, each of which was synthetically conjugated with a polyacrylamide backbone, for Stx‐neutralizing activity. Galacto‐trehalose was designed as a Gb2 mimicking, unnatural Stx‐ligand that was expected to show tolerance to enzymatic degradation in vivo. Galacto‐trehalose copolymer showed neutralizing activity against Stx‐1 but not Stx‐2 in a HeLa cell cytotoxicity assay. It was thought that galacto‐trehalose copolymer could be a lead compound for the treatment of Stx‐mediated diseases, although it requires modification to show neutralizing activity to Stx‐2. The Gb3 copolymer with high sugar unit density showed stronger neutralizing activity against Stx‐2 than those with lower density. However, the density‐dependency of the neutralizing activity was less obvious against Stx‐1. Intravenous administration of the Gb3 copolymer prevented death in mice lethally infected with Stx‐1‐ and Stx‐2‐producing E. coli O157:H7. Thus, we demonstrated that the artificial Gb3 copolymer could neutralize Stx‐1 and the more clinically relevant Stx‐2 in vitro and effectively inhibit Stx toxicity in vivo.
- 1 February 2001
- Published by Elsevier in Journal of Autoimmunity
- Vol. 16 (1) , 29-36
Production of Experimental Autoimmune Sialadenitis in Mice Immunized with Homologous Salivary Gland Extract andKlebsiella O3 Lipopolysaccharide
- 1 February 2001
- Published by Elsevier in Journal of Autoimmunity
- Vol. 16 (1) , 29-36
Production of Experimental Autoimmune Sialadenitis in Mice Immunized with Homologous Salivary Gland Extract andKlebsiella O3 Lipopolysaccharide
- Open Access
- 1 May 2000
- Published by Wiley in Molecular Microbiology
- Vol. 36 (4) , 796-805
Molecular structure of bacterial endotoxin (Escherichia coli Re lipopolysaccharide): implications for formation of a novel heterogeneous lattice structure
Analyses of crystals of Escherichia coli Re lipopolysaccharide (LPS) formed after storage in 1% triethylamine indicate that the LPS molecules are assembled to form a monolayered structure consisting of a novel heterogeneous lattice structure, the greater part of which is occupied by one kind of lattice (lattice I), corresponding to the acyl chain portion of lipid A, and the remainder is occupied by the other kind of lattice (lattice II), corresponding to the 3‐deoxy‐dmanno‐octulosonic acid (dOclA) dimer and the N‐acetylglucosamine disaccharide of lipid A. X‐ray diffraction reveals that the type of cell is monoclinic (a = 5.53 Å, b = 27.2 Å, c = 6.47 Å , α = 90°, β = 125.8°, γ = 90°). Atomic force microscopy shows that crystals consist of multiple layers; the thickness of a layer corresponds to the b‐axis value, and two types of surface topographies are visualized. One, regarded as the view onto the acyl chain ends, is two‐dimensional arrays of oval bodies that constitute the lattice, with the lattice constants corresponding to the a‐ and c‐axes and the angle of β (lattice I). The other, regarded as the view onto the dOclA dimers, is two‐dimensional arrays of dromedary‐back‐like bodies that constitute the lattice with axes of 9.0 and 10.7 Å and the angle of 65° formed by both axes (lattice II). Based on these results, we present the molecular model of E. coli Re LPS.
- 1 May 2000
- Published by Wiley in Molecular Microbiology
- Vol. 36 (4) , 796-805
Open AccessMolecular structure of bacterial endotoxin (Escherichia coli Re lipopolysaccharide): implications for formation of a novel heterogeneous lattice structure
Analyses of crystals of Escherichia coli Re lipopolysaccharide (LPS) formed after storage in 1% triethylamine indicate that the LPS molecules are assembled to form a monolayered structure consisting of a novel heterogeneous lattice structure, the greater part of which is occupied by one kind of lattice (lattice I), corresponding to the acyl chain portion of lipid A, and the remainder is occupied by the other kind of lattice (lattice II), corresponding to the 3‐deoxy‐dmanno‐octulosonic acid (dOclA) dimer and the N‐acetylglucosamine disaccharide of lipid A. X‐ray diffraction reveals that the type of cell is monoclinic (a = 5.53 Å, b = 27.2 Å, c = 6.47 Å , α = 90°, β = 125.8°, γ = 90°). Atomic force microscopy shows that crystals consist of multiple layers; the thickness of a layer corresponds to the b‐axis value, and two types of surface topographies are visualized. One, regarded as the view onto the acyl chain ends, is two‐dimensional arrays of oval bodies that constitute the lattice, with the lattice constants corresponding to the a‐ and c‐axes and the angle of β (lattice I). The other, regarded as the view onto the dOclA dimers, is two‐dimensional arrays of dromedary‐back‐like bodies that constitute the lattice with axes of 9.0 and 10.7 Å and the angle of 65° formed by both axes (lattice II). Based on these results, we present the molecular model of E. coli Re LPS.
- 1 November 1994
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 17 (11) , 2100-2105
Frequency Dependent Effects of Class I Antiarrhythmic Agents Studied in Patients with Implanted Pacemakers
Use and frequency dependency are common properties of Class I antiarrhythmic agents, which block cardiac sodium channels in vitro. The purpose of this study was to examine the rate dependent effects of Class I agents on ventricular conduction in humans in a crossover fashion. Twelve patients with implanted pacemakers who required antiarrhythmic therapy were studied. Four Class I agents were administered as follows: lidocaine. 1 mg/kg bolus followed by 4 mg/min infusion; disopyramide, 1 mg/kg bolus followed by 0.02 mg/kg per hour; aprindine, 1 mg/kg bolus followed by 4 mg/min infusion; and flecainide, 100 mg/day orally for 1 week. Trains of ventricular test stimuli between 70–180 ppm were applied during stable VVI pacing at 60 ppm. QRS duration was determined using signal‐averaged as well as standard ECCs. Lidocaine produced significant QRS prolongation at rates > 110 ppm (3.0%± 1.4% at 120 ppm. P < 0.05; 7.2%± 1.8% at 180 ppm, P < 0.01). Aprindine, disopyramide. and flecainide produced significant QRS prolongation at rates as low as 70 ppm and in a frequency dependent manner: 12.7%± 1.5%, 9.6%± 1.6%, and 13.3%± 2.8% at 70 ppm, respectively, (P < 0.01); 21.6%± 0.6%, 14.7%± 2.4%, and 29.9%± 4.2% at 180 ppm, respectively, (P < 0.01). Time constants of the single exponential development of QRS prolongation when the pacing rate was abruptly increased to 150 ppm were 0.09 ± 0.02 sec for lidocaine, 5.1 ± 1.2 sec for aprindine, 8.1 ± 1.7 sec for disopyramide, and 11.9 ± 1.4 sec for flecainide. These findings indicate that therapeutic doses of Class I agents cause a rate dependent depression of ventricular conduction in humans that is comparable to their blocking effect on cardiac sodium channels.
- 1 November 1994
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 17 (11) , 2100-2105
Frequency Dependent Effects of Class I Antiarrhythmic Agents Studied in Patients with Implanted Pacemakers
Use and frequency dependency are common properties of Class I antiarrhythmic agents, which block cardiac sodium channels in vitro. The purpose of this study was to examine the rate dependent effects of Class I agents on ventricular conduction in humans in a crossover fashion. Twelve patients with implanted pacemakers who required antiarrhythmic therapy were studied. Four Class I agents were administered as follows: lidocaine. 1 mg/kg bolus followed by 4 mg/min infusion; disopyramide, 1 mg/kg bolus followed by 0.02 mg/kg per hour; aprindine, 1 mg/kg bolus followed by 4 mg/min infusion; and flecainide, 100 mg/day orally for 1 week. Trains of ventricular test stimuli between 70–180 ppm were applied during stable VVI pacing at 60 ppm. QRS duration was determined using signal‐averaged as well as standard ECCs. Lidocaine produced significant QRS prolongation at rates > 110 ppm (3.0%± 1.4% at 120 ppm. P < 0.05; 7.2%± 1.8% at 180 ppm, P < 0.01). Aprindine, disopyramide. and flecainide produced significant QRS prolongation at rates as low as 70 ppm and in a frequency dependent manner: 12.7%± 1.5%, 9.6%± 1.6%, and 13.3%± 2.8% at 70 ppm, respectively, (P < 0.01); 21.6%± 0.6%, 14.7%± 2.4%, and 29.9%± 4.2% at 180 ppm, respectively, (P < 0.01). Time constants of the single exponential development of QRS prolongation when the pacing rate was abruptly increased to 150 ppm were 0.09 ± 0.02 sec for lidocaine, 5.1 ± 1.2 sec for aprindine, 8.1 ± 1.7 sec for disopyramide, and 11.9 ± 1.4 sec for flecainide. These findings indicate that therapeutic doses of Class I agents cause a rate dependent depression of ventricular conduction in humans that is comparable to their blocking effect on cardiac sodium channels.